Business Description
Equasens
ISIN : FR0012882389
Total Employee Number:
834Compare
Compare
Traded in other countries / regions
EQS.France0R9T.UKPHF.Germany IPO Date
2018-09-10Description
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.43 | |||||
Equity-to-Asset | 0.58 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 0.86 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.4 | |||||
3-Year EBITDA Growth Rate | 0.9 | |||||
3-Year EPS without NRI Growth Rate | -5.4 | |||||
3-Year FCF Growth Rate | 0.3 | |||||
3-Year Book Growth Rate | 10 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 11.47 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.83 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.44 | |||||
Quick Ratio | 1.34 | |||||
Cash Ratio | 0.75 | |||||
Days Inventory | 52.75 | |||||
Days Sales Outstanding | 73.99 | |||||
Days Payable | 82.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.48 | |||||
3-Year Dividend Growth Rate | 6 | |||||
Shareholder Yield % | 2.58 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 68.74 | |||||
Operating Margin % | 20.24 | |||||
Net Margin % | 16.63 | |||||
EBITDA Margin % | 30 | |||||
FCF Margin % | 19.95 | |||||
OCF Margin % | 25.05 | |||||
ROE % | 16.26 | |||||
ROA % | 9.4 | |||||
ROIC % | 13.12 | |||||
3-Year ROIIC % | -16.07 | |||||
ROC (Joel Greenblatt) % | 179.45 | |||||
ROCE % | 16.94 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 13.59 | |||||
Forward PE Ratio | 17.65 | |||||
PE Ratio without NRI | 13.55 | |||||
Shiller PE Ratio | 14.55 | |||||
Price-to-Owner-Earnings | 10.62 | |||||
PEG Ratio | 3.76 | |||||
PS Ratio | 2.25 | |||||
PB Ratio | 2.1 | |||||
Price-to-Tangible-Book | 7.04 | |||||
Price-to-Free-Cash-Flow | 11.32 | |||||
Price-to-Operating-Cash-Flow | 9.02 | |||||
EV-to-EBIT | 9.49 | |||||
EV-to-EBITDA | 7.01 | |||||
EV-to-Revenue | 2.09 | |||||
EV-to-FCF | 10.89 | |||||
Price-to-GF-Value | 0.62 | |||||
Price-to-Projected-FCF | 0.87 | |||||
Price-to-DCF (Earnings Based) | 1.21 | |||||
Price-to-DCF (FCF Based) | 0.79 | |||||
Price-to-Median-PS-Value | 0.41 | |||||
Price-to-Graham-Number | 2.06 | |||||
Earnings Yield (Greenblatt) % | 10.55 | |||||
FCF Yield % | 9.21 | |||||
Forward Rate of Return (Yacktman) % | 10.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Equasens Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 236.52 | ||
| EPS (TTM) (€) | 2.59 | ||
| Beta | 0.0798 | ||
| 3-Year Sharpe Ratio | -36.58 | ||
| 3-Year Sortino Ratio | -3.45 | ||
| Volatility % | 2.37 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 52.77 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 52.77 - 52.77 | ||
| Shares Outstanding (Mil) | 15.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Equasens Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Equasens Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 1.400000 Cash Dividend | 2026-07-01 | 52.77 (+0.00%) | ||
| EUR 1.250000 Cash Dividend | 2025-07-02 | 52.77 (+0.00%) | ||
| EUR 1.250000 Cash Dividend | 2024-07-02 | 52.77 (+0.00%) |
Show
Entries
Equasens Frequently Asked Questions
What is Equasens(FRA:PHF)'s stock price today?
The current price of FRA:PHF is €52.77. The 52 week high of FRA:PHF is €52.77 and 52 week low is €52.77.
When is next earnings date of Equasens(FRA:PHF)?
The next earnings date of Equasens(FRA:PHF) is .
Does Equasens(FRA:PHF) pay dividends? If so, how much?
Equasens(FRA:PHF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Equasens
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers